Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome

Luca Miele, Antonio Lanzone, Maurizio Pompili, Rosanna Apa, Francesca Sagnella, Daniela Martinez, Francesca Moro, Andrea Morciano, Consuelo Cefalo

Risultato della ricerca: Contributo in rivistaArticolo in rivista

31 Citazioni (Scopus)

Fingerprint

Entra nei temi di ricerca di 'Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome'. Insieme formano una fingerprint unica.

Medicine & Life Sciences